SCHEMBL9128172

SCHEMBL9128172

COc1ccccc1OCCNCC(OC)c1ccc(C)c(S(N)(=O)=O)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 11/20 0.78
▸ ADRA1A P35348 8/20 0.78
▸ DRD2 P14416 5/20 0.78
▸ DRD3 P35462 5/20 0.78
▸ HTR1A P08908 5/20 0.78
▸ ADRB1 P08588 4/20 0.78
▸ ADRA2A P08913 2/20 0.78
▸ ADRA2B P18089 2/20 0.78
▸ ADRA2C P18825 2/20 0.78
▸ HTR2A P28223 2/20 0.78
▸ HTR2B P41595 2/20 0.78
▸ KCNH2 Q12809 2/20 0.78
▸ SLC6A4 P31645 1/20 0.78
▸ HRH1 P35367 1/20 0.78
▸ PDE4D Q08499 1/20 0.78
▸ DRD1 P21728 3/20 0.50
▸ DRD4 P21917 3/20 0.50
▸ ADRA1D P25100 7/20 0.44
▸ ADRA1B P35368 7/20 0.44
▸ HTR7 P34969 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9122055 0.89 ADRB2 (0.80) ADRB2ADRA1ADRD2DRD3HTR1A
SCHEMBL10956021 0.88 ADRB2 (0.78) ADRB2ADRA1ADRD2DRD3HTR1A
Amosulalol SCHEMBL48933 0.88 ADRB2 (1.00) ADRB2ADRA1ADRD2DRD3HTR1A
Amosulalol SCHEMBL6509394 0.88 ADRB2 (1.00) ADRB2ADRA1ADRD2DRD3HTR1A
Amosulalol SCHEMBL30136493 0.88 ADRB2 (1.00) ADRB2ADRA1ADRD2DRD3HTR1A
SCHEMBL11013459 0.88 ADRB2 (0.78) ADRB2ADRA1ADRD2DRD3HTR1A
Amosulalol SCHEMBL50631 0.87 ADRB2 (0.98) ADRB2ADRA1ADRD2DRD3HTR1A
Hydrochloric Acid SCHEMBL9124264 0.87 ADRB2 (0.77) ADRB2ADRA1ADRD2DRD3HTR1A
Amosulalol SCHEMBL11020103 0.87 ADRB2 (0.98) ADRB2ADRA1ADRD2DRD3HTR1A
Iodide SCHEMBL9124432 0.87 ADRB2 (0.77) ADRB2ADRA1ADRD2DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5447958-A Treatment of hypertension, congestive heart failure, angina pectoris, lower urinary tract dysfunction, prostatic hypertrophy YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-09-05 — — US disclosed
US-5391825-A ADRENERGIC BLOCKING AGENTS; CARDIOVASCULAR DISORDERS; UREGENITAL DISORDERS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1995-02-21 — — US disclosed
US-4987152-A ADRENERGIC BLOCKING AGENTS, HYPOTENSIVES, CONGESTIVE HEART FAILURE YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1991-01-22 — — US disclosed
US-4868216-A ANTIADRENERGIC AGENTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1989-09-19 — — US disclosed
US-4761500-A CONGESTIVE HEART FAILURE YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1988-08-02 — — US disclosed
US-4731478-A ADRENERGIC BLOCKING AGENTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1988-03-15 — — US disclosed
US-4703063-A TAMSULOSIN HYDROCHLORIDE; antihypertensive agent and an agent for the treatment of congestive heart failure YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1987-10-27 — — US disclosed
US-4558156-A ADRENERGIC BLOCKING AGENT, HYPOTENSIVE AGENT YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1985-12-10 — — US disclosed
EP-0034432-B1 SULFAMOYL-SUBSTITUTED PHENETHYLAMINE DERIVATIVES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS, CONTAINING THEM YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1984-04-25 — — EP disclosed
US-4373106-A Sulfamoyl-substituted phenethylamine derivatives and process of producing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1983-02-08 — — US disclosed
EP-0034432-A2 Sulfamoyl-substituted phenethylamine derivatives, their preparation, and pharmaceutical compositions, containing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1981-08-26 — — EP disclosed
Send feedback